Day One Biopharmaceuticals (DAWN) News Today $6.80 +0.07 (+1.04%) Closing price 07/3/2025 03:00 PM EasternExtended Trading$6.80 0.00 (0.00%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DAWN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period When Will Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Breakeven?July 1, 2025 | finance.yahoo.comDay One Biopharmaceuticals Inc News (DAWN) - Investing.comJune 24, 2025 | investing.comTimesSquare Capital U.S. Small Cap Growth Strategy Exited its Position in Day One Biopharmaceuticals Inc. (DAWN)June 23, 2025 | msn.comDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of "Buy" by BrokeragesJune 16, 2025 | marketbeat.comBank of America Corp DE Has $260,000 Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)June 15, 2025 | marketbeat.comDay One Appoints Michael Vasconcelles, M.D., as Head of Research and DevelopmentJune 10, 2025 | finance.yahoo.comDay One Appoints Michael Vasconcelles, M.D., as Head of Research and DevelopmentJune 10, 2025 | globenewswire.comH.C. Wainwright Maintains Buy Rating on Day One Biopharmaceuticals (DAWN), Keeps PTJune 5, 2025 | msn.comJonesTrading Maintains Buy Rating on Day One Biopharmaceuticals (DAWN) Following Ojemda’s FDA ApprovalJune 5, 2025 | msn.comDay One Biopharmaceuticals: Strong Ojemda Potential In Q2 And Solid Rationale For DAY-301June 4, 2025 | seekingalpha.comDay One Biopharmaceuticals (NASDAQ:DAWN) Trading 9% Higher - Still a Buy?June 3, 2025 | marketbeat.comDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Bought by Millennium Management LLCJune 2, 2025 | marketbeat.comDay One Biopharmaceuticals (NASDAQ:DAWN) Shares Down 4.9% - Should You Sell?May 31, 2025 | marketbeat.comTwo Sigma Investments LP Cuts Stock Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 31, 2025 | marketbeat.comDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Rating of "Buy" from BrokeragesMay 24, 2025 | marketbeat.comNorthern Trust Corp Grows Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 22, 2025 | marketbeat.comVestal Point Capital LP Sells 1,060,000 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 21, 2025 | marketbeat.comTema Etfs LLC Invests $1.09 Million in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 20, 2025 | marketbeat.comInsider Selling: Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Insider Sells 3,927 Shares of StockMay 20, 2025 | insidertrades.comJanus Henderson Group PLC Reduces Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 18, 2025 | marketbeat.comParkman Healthcare Partners LLC Purchases 76,334 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 16, 2025 | marketbeat.comParkwood LLC Takes $3.48 Million Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 16, 2025 | marketbeat.comOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes $634,000 Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 16, 2025 | marketbeat.comIs Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now?May 14, 2025 | finance.yahoo.comHudson Bay Capital Management LP Has $11.66 Million Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 14, 2025 | marketbeat.comIs Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now?May 13, 2025 | msn.comDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Purchased by Dimensional Fund Advisors LPMay 12, 2025 | marketbeat.comHC Wainwright Analysts Lower Earnings Estimates for DAWNMay 11, 2025 | marketbeat.comWedbush Has Positive Estimate for DAWN Q2 EarningsMay 11, 2025 | marketbeat.comDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Acquired by Estuary Capital Management LPMay 11, 2025 | marketbeat.comEquities Analysts Set Expectations for DAWN FY2028 EarningsMay 10, 2025 | marketbeat.comBrokers Offer Predictions for DAWN Q1 EarningsMay 10, 2025 | marketbeat.comDay One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 12-Month Low Following Analyst DowngradeMay 10, 2025 | marketbeat.comDay One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Up Following Earnings BeatMay 9, 2025 | marketbeat.comDay One Biopharmaceuticals (NASDAQ:DAWN) Price Target Cut to $27.00 by Analysts at Needham & Company LLCMay 9, 2025 | marketbeat.comIs Day One Biopharmaceuticals, Inc. (DAWN) the Low Risk High Reward Stock Set to Triple by 2030?May 9, 2025 | insidermonkey.comHsbc Holdings PLC Makes New Investment in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 9, 2025 | marketbeat.comDay One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ...May 8, 2025 | uk.finance.yahoo.comDay One Biopharmaceuticals, Inc.: Day One Reports First Quarter 2025 Financial Results and Corporate ProgressMay 7, 2025 | finanznachrichten.deDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q1 2025 Earnings Call TranscriptMay 7, 2025 | msn.comDay One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Report Preview: What to ExpectMay 7, 2025 | finance.yahoo.comDay One Biopharmaceuticals, Inc. (DAWN) Q1 2025 Earnings Call TranscriptMay 6, 2025 | seekingalpha.comDay One Biopharmaceuticals, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 6, 2025 | seekingalpha.comDay One Reports First Quarter 2025 Financial Results and Corporate ProgressMay 6, 2025 | globenewswire.comAlyeska Investment Group L.P. Takes Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 6, 2025 | marketbeat.comBoxer Capital Management LLC Acquires Shares of 1,189,943 Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 4, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Sells 838,751 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 4, 2025 | marketbeat.comRA Capital Management L.P. Cuts Stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)May 3, 2025 | marketbeat.comDay One Biopharmaceuticals (DAWN) Projected to Post Earnings on TuesdayMay 1, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 100,000 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)April 30, 2025 | marketbeat.com Get Day One Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DAWN and its competitors with MarketBeat's FREE daily newsletter. Email Address DAWN Media Mentions By Week DAWN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DAWN News Sentiment▼0.000.58▲Average Medical News Sentiment DAWN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DAWN Articles This Week▼14▲DAWN Articles Average Week Get Day One Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DAWN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Organon & Co. News Today AMNEAL PHARMACEUTICALS News Today Mirum Pharmaceuticals News Today Xenon Pharmaceuticals News Today Bausch Health Cos News Today ImmunityBio News Today Arrowhead Pharmaceuticals News Today Apellis Pharmaceuticals News Today Twist Bioscience News Today Vericel News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DAWN) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Day One Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Day One Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
